These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Impact of nesiritide on renal function and mortality in patients suffering from heart failure. Dontas ID; Xanthos T; Dontas I; Lelovas P; Papadimitriou L Cardiovasc Drugs Ther; 2009 Jun; 23(3):221-33. PubMed ID: 19252976 [TBL] [Abstract][Full Text] [Related]
6. Nesiritide is beneficial or harmful to patients with decompensated acute congestive heart failure. Ma X; Sun F; Ma J Int J Cardiol; 2015; 187():387-8. PubMed ID: 25841132 [No Abstract] [Full Text] [Related]
7. Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment. Munger MA; Ng TM; Van Tassell BW Pharmacotherapy; 2007 May; 27(5):619-25. PubMed ID: 17461695 [TBL] [Abstract][Full Text] [Related]
8. Nesiritide in acute decompensated heart failure. Kramer DB N Engl J Med; 2011 Oct; 365(16):1547; discussion 1547. PubMed ID: 22010930 [No Abstract] [Full Text] [Related]
9. Risk of death associated with nesiritide in patients with acutely decompensated heart failure. Aaronson KD; Sackner-Bernstein J JAMA; 2006 Sep; 296(12):1465-6. PubMed ID: 17003394 [No Abstract] [Full Text] [Related]
10. The ASCEND-HF trial: an acute study of clinical effectiveness of nesiritide and decompensated heart failure. Dandamudi S; Chen HH Expert Rev Cardiovasc Ther; 2012 May; 10(5):557-63. PubMed ID: 22651831 [TBL] [Abstract][Full Text] [Related]
11. Concomitant use of nesiritide and milrinone in decompensated congestive heart failure. Smull DL; Jorde UP Am J Health Syst Pharm; 2005 Feb; 62(3):291-5. PubMed ID: 15719588 [No Abstract] [Full Text] [Related]
12. Nesiritide and Me. Kittleson MM Circ Heart Fail; 2018 Aug; 11(8):e005440. PubMed ID: 30354567 [No Abstract] [Full Text] [Related]
13. Does nesiritide reduce mortality and readmission in decompensated heart failure? Bernardo WM; Moreira FT Rev Assoc Med Bras (1992); 2012; 58(2):133-4. PubMed ID: 22569604 [No Abstract] [Full Text] [Related]
14. Re: Critical review and recommendations for nesiritide use in the Emergency Department. Levine M J Emerg Med; 2007 Feb; 32(2):207-8; author reply 208-9. PubMed ID: 17307636 [No Abstract] [Full Text] [Related]
15. [Nesiritide in heart failure: commercial success or therapeutic advance?]. Stampfli T; Perrier A Rev Med Suisse; 2006 Jan; 2(50):295-8. PubMed ID: 16503047 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of nesiritide in patients with acute decompensated heart failure. DeWald TA; Hernandez AF Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):159-69. PubMed ID: 20136602 [TBL] [Abstract][Full Text] [Related]
17. Observation unit treatment of heart failure with nesiritide: results from the proaction trial. Peacock WF; Holland R; Gyarmathy R; Dunbar L; Klapholz M; Horton DP; de Lissovoy G; Emerman CL J Emerg Med; 2005 Oct; 29(3):243-52. PubMed ID: 16183441 [TBL] [Abstract][Full Text] [Related]
18. In brief: nesiritide (Natrecor). Med Lett Drugs Ther; 2011 Nov; 53(1377):92. PubMed ID: 22089926 [No Abstract] [Full Text] [Related]
19. Nesiritide: harmful or harmless? Dorsch MP; Rodgers JE Pharmacotherapy; 2006 Oct; 26(10):1465-78. PubMed ID: 16999657 [TBL] [Abstract][Full Text] [Related]
20. Nesiritide, heart failure, and renal dysfunction: irrational exuberance or throwing the baby out with the bathwater. Editorial to: "Impact of nesiritide on renal function and mortality in patients suffering from heart failure" by Dontas et al. Witteles RM Cardiovasc Drugs Ther; 2009 Jun; 23(3):183-6. PubMed ID: 19353257 [No Abstract] [Full Text] [Related] [Next] [New Search]